"This protocol represents a significant step forward in standardising care for women recovering from vesicovaginal fistula ...

This World Prematurity Day, FIGO calls on healthcare providers, policymakers, and communities to champion better care for ...

We have recently witnessed some policy changes that have led to the expanded registration of mifepristone, a crucial ...

FIGO and the World Health Organization (WHO) are collaborating to enhance family planning care globally, by increasing ...

FIGO’s Improving access to essential medicines to reduce postpartum haemorrhage (PPH) morbidity and mortality (IAP) project ...

Project leads: Professor Sean Kehoe, Past Chair and current member of the FIGO Committee on Women's Cancer; Professor Joanna ...

FIGO’s Self-Management of Abortion (SMA) Project, which concluded in May 2024, worked to implement WHO Abortion Guideline on ...

FIGO’s Combatting Post-Partum Hemorrhage (PPH) project aims to provide technical support to selected regional and national ...

FIGO’s Accelerating Measurable Progress and Leveraging Investments for Postpartum Haemorrhage Impact (AMPLI-PPHI) project ...

The key goal of the FIGO Saving Mothers and Newborns Initiative was to contribute to the reduction in maternal and newborn ...

The following people are all recipients of the FIGO Awards in Recognition of Women Obstetricians/Gynaecologists.

Background: Post-partum haemorrhage (PPH) is the most significant direct cause of maternal mortality in low-resource ...